Ambu A/S (OTCMKTS:AMBBY) Shares Gap Down – Should You Sell?

Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) gapped down before the market opened on Wednesday . The stock had previously closed at $9.51, but opened at $8.5450. Ambu A/S shares last traded at $8.5450, with a volume of 151 shares trading hands.

Ambu A/S Stock Performance

The company has a market cap of $2.01 billion, a PE ratio of 30.52 and a beta of 0.98. The company has a current ratio of 2.92, a quick ratio of 1.73 and a debt-to-equity ratio of 0.08. The business’s 50 day moving average is $10.12 and its two-hundred day moving average is $11.73.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.07 EPS for the quarter. Ambu A/S had a return on equity of 8.03% and a net margin of 7.81%.The business had revenue of $246.39 million for the quarter.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.